Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours

Neuropathology and Applied Neurobiology

Volumn 30, Issue 4, 2004, Pages 338-350

  Zamecnik J ^a   Vargova L ^a   Homola, A ^a   Kodet, R ^a   Sykova E ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Collagen; Diffusion; Extracellular matrix; Glioma; Tenascin; Vitronectin

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN; LAMININ; TENASCIN; VITRONECTIN;

ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; BLOOD BRAIN BARRIER; CANCER GRADING; CELL DENSITY; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DIFFUSION; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IONTOPHORESIS; MALE; PRIORITY JOURNAL; TEMPORAL LOBE; TUMOR VOLUME;

AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; DIFFUSION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; IONTOPHORESIS; MALE; PARAFFIN EMBEDDING; TEMPORAL LOBE;

EID: 4344618969     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2003.00541.x     Document Type: Article

References (48)

1. Giese A, Rief MD, Loo MA, Berens ME. Determinants of human astrocytoma migration. Cancer Res 1994; 54: 3897-904
2. Goldbrunner RH, Bernstein JJ, Tonn JC. Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) 1999; 141: 295-305
3. Sykova E, Mazel T, Vargova L, Vorisek I, Prokopova-Kubinova S. Extracellular space diffusion and pathological states. Prog Brain Res 2000; 125: 155-78
4. Sykova E. Glial diffusion barriers during aging and pathological states. Prog Brain Res 2001; 132: 339-63
5. Nicholson C, Sykova E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci 1998; 21: 207-15
6. Nicholson C, Phillips JM. Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol 1981; 321: 225-57
7. Roitbak T, Sykova E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 1999; 28: 40-8
8. Vargova L, Homola A, Zamecnik J, Tichy M, Benes V, Sykova E. Diffusion parameters of the extracellular space in human gliomas. Glia 2003; 42: 77-88
9. Sykova E, Mazel T, Simonova Z. Diffusion constraints and neuron-glia interaction during aging. Exp Gerontol 1998; 33: 837-51
10. Sykova E, Vargova L, Prokopova S, Simonova Z. Glial swelling and astrogliosis produce diffusion barriers in the rat spinal cord. Glia 1999; 25: 56-70
11. Chintala SK, Rao JK. Invasion of human glioma: role of extracellular matrix proteins. Front Biosci 1996; 1: d324-39
12. Gladson CL. The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 1999; 58: 1029-40
13. Kleihues P, Cavenee WK, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press, 2000; 10-51
14. Prokopova S, Vargova L, Sykova E. Heterogeneous and anisotropic diffusion in the developing rat spinal cord. Neuroreport 1997; 8: 3527-32
15. Lehmenkuhler A, Sykova E, Svoboda J, Zilles K, Nicholson C. Extracellular space parameters in the rat neocortex and subcortical white matter during postnatal development determined by diffusion analysis. Neuroscience 1993; 55: 339-51
16. Sykova E. Ion-selective electrodes. In Monitoring Neuronal Cells: a Practical Approach. Ed. J Stamford. New York: Oxford University Press, 1992; 261-82
17. Gerdes J, Becker MH, Key G, Cattoretti G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992; 168: 85-6
18. Holden JA, Townsend JJ. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival. Mod Pathol 1999; 12: 1094-100
19. Bakay L. The extracellular space in brain tumours. II. The sucrose space. Brain 1970; 93: 699-708
20. Matthews CM, Molinaro G. A study of the relative value of radioactive substances used for brain tumor localization and of the mechanism of tumor: brain concentration. Uptake in transplantable fibrosarcoma, brain and other organs in the rat. Br J Exp Pathol 1963; 44: 260-77
21. Bolteus AJ, Berens ME, Pilkington GJ. Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 2001; 1: 225-32
22. Chintala SK, Tonn JC, Rao JS. Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 1999; 17: 495-502
23. Quist AP, Rhee SK, Lin H, Lal R. Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol 2000; 148: 1063-74
24. Ye ZC, Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999; 59: 4383-91
25. Mahesparan R, Tysnes BB, Read TA, Enger PO, Bjerkvig R, Lund-Johansen M. Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro. Acta Neuropathol (Berl) 1999; 97: 231-9
26. McKeever PE, Fligiel SE, Varani J, Castle RL, Hood TW. Products of cells cultured from gliomas. VII. Extracellular matrix proteins of gliomas which contain glial fibrillary acidic protein. Lab Invest 1989; 60: 286-95
27. 7 Paulus W, Huettner C, Tonn JC. Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 1994; 58: 841-6
28. Bellon G, Caulet T, Cam Y, Pluot M, Poulin G, Pytlinska M, Bernard MH. Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol (Berl) 1985; 66: 245-52
29. Chintala SK, Sawaya R, Gokaslan ZL, Fuller G, Rao JS. Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett 1996; 101: 107-14
30. Rucklidge GJ, Dean V, Robins SP, Mella O, Bjerkvig R. Immunolocalization of extracellular matrix proteins during brain tumor invasion in BD IX rats. Cancer Res 1989; 49: 5419-23
31. Tysnes BB, Mahesparan R, Thorsen F, Haugland HK, Porwol T, Enger PO, Lund-Johansen M, Bjerkvig R. Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. Int J Dev Neurosci 1999; 17: 531-9
32. Paulus W, Roggendorf W, Schuppan D. Immunohistochemical investigation of collagen subtypes in human glioblastomas. Virchows Arch 1988; 413: 325-32
33. Eyre D. Collagen of articular cartilage. Arthritis Res 2002; 4: 30-5
34. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol (Berl) 1993; 85: 481-7
35. Oz B, Karayel FA, Gazio NL, Ozlen F, Balci K. The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol Oncol Res 2000; 6: 118-24
36. Gladson CL, Cheresh DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 1991; 88: 1924-32
37. Crossin KL. Tenascin: a multifunctional extracellular matrix protein with a restricted distribution in development and disease. J Cell Biochem 1996; 61: 592-8
38. Kim CH, Bak KH, Kim YS, Kim JM, Ko Y, Oh SJ, Kim KM, Hong EK. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg Neurol 2000; 54: 235-40
39. Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M, Greco MA. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 1995; 55: 907-14
40. Joester A, Faissner A. The structure and function of tenascin in the nervous system. Matrix Biol 2001; 20: 13-22
41. Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 2002; 98: 362-9
42. Rascher G, Fischmann A, Kroger S, Duffner F, Grote EH, Wolburg H. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol (Berl) 2002; 104: 85-91
43. Vorisek I, Antonova T, Mazel T, Hajek M, Sykova E. Diffusion and extracellular space volume fraction in the brain of mice lacking tenascin-R or HNK1 sulfotransferase. Proc Intl Soc Mag Reson Med 2003; 11: 1983
44. Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Creissard P. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur J Cancer 1993; 29A: 1012-17
45. Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP. The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 1989; 143: 150-9
46. Margolis RK, Margolis RU. Nervous tissue proteoglycans. Experientia 1993; 49: 429-16
47. Read TA, Thorsen F, Bjerkvig R. Localised delivery of therapeutic agents to CNS malignancies: old and new approaches. Curr Pharm Biotechnol 2002; 3: 257-73
48. Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE, Cokgor I, McLendon RE, Pegram CN, Provenzale JM, Quinn JA, Rich JN, Regalado LV, Sampson JH, Shafman TD, Wikstrand CJ, Wong TZ, Zhao XG, Zalutsky MR, Bigner DD. Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. J Clin Oncol 2002; 20: 1389-97